CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Citius Pharmaceuticals, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.43−0.03 (-7.00%)
Close on Oct 19, 2026
- Market cap
- $11.20M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Dec 27, 2024(first seen in filings) | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Nov 26, 2024 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Aug 14, 2017(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Jun 9, 2017 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |